Skip to content

Tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate

C16H21IN5O3P — CID 171067097

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACtert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate
SMILESCN(C)/C=N/C(=O)c1cc(NC(=O)OC(C)(C)C)c2cnn(PI)c2c1
InChIInChI=1S/C16H21IN5O3P/c1-16(2,3)25-15(24)20-12-6-10(14(23)18-9-21(4)5)7-13-11(12)8-19-22(13)26-17/h6-9,26H,1-5H3,(H,20,24)/b18-9+
InChIKeyIPOIFDFFKJVYTH-GIJQJNRQSA-N
MW489.25 g/mol
LogP3.90
Rot. Bonds4

About Tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate

Tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate (PubChem CID 171067097) has the molecular formula C16H21IN5O3P and a molecular weight of 489.25 g/mol. Its IUPAC name is tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate.

Molecular Properties

Compound NameTert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate
PubChem CID171067097
Molecular FormulaC16H21IN5O3P
Molecular Weight489.25 g/mol
Exact Mass489.04
IUPAC Nametert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate
SMILESCN(C)/C=N/C(=O)c1cc(NC(=O)OC(C)(C)C)c2cnn(PI)c2c1
InChIInChI=1S/C16H21IN5O3P/c1-16(2,3)25-15(24)20-12-6-10(14(23)18-9-21(4)5)7-13-11(12)8-19-22(13)26-17/h6-9,26H,1-5H3,(H,20,24)/b18-9+
InChIKeyIPOIFDFFKJVYTH-GIJQJNRQSA-N
XLogP3.90
TPSA88.82 Ų
H-Bond Donors1
H-Bond Acceptors5
Rotatable Bonds4
Heavy Atoms26
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500489.25
LogP ≤ 53.90
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'}, {'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze Tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of Tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate?
The IUPAC name of Tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate (CID 171067097) is tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate.
What is the SMILES notation for Tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate?
The canonical SMILES for Tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate is CN(C)/C=N/C(=O)c1cc(NC(=O)OC(C)(C)C)c2cnn(PI)c2c1.
What is the InChIKey of Tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate?
The InChIKey is IPOIFDFFKJVYTH-GIJQJNRQSA-N. The full InChI is InChI=1S/C16H21IN5O3P/c1-16(2,3)25-15(24)20-12-6-10(14(23)18-9-21(4)5)7-13-11(12)8-19-22(13)26-17/h6-9,26H,1-5H3,(H,20,24)/b18-9+.
What are the key properties of Tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate?
Tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate has a molecular weight of 489.25 g/mol, XLogP of 3.90, 4 rotatable bonds, 1 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for Tert-butyl N-[6-(dimethylaminomethylidenecarbamoyl)-1-iodophosphanylindazol-4-yl]carbamate is sourced from PubChem (CID 171067097), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.